Inhaled nitric oxide-induced rebound pulmonary hypertension: Role for endothelin-1

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Mcmullan, D Michael ^a   Bekker, Janine M ^b   Johengen, Michael J ^b   Hendricks Munoz, Kaken ^c   Gerrets, Rene ^c   Black, Stephen M ^d   Fineman, Jeffrey R ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelin receptor; Endothelium derived factors; Pulmonary heart disease; Pulmonary hypertension of the newborn

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; NITRIC OXIDE; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; COR PULMONALE; GENE EXPRESSION; INHALATION; LAMB; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; WESTERN BLOTTING;

EID: 0034996074     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h777     Document Type: Article

References (41)

1. Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. Atz A, Adatia I, and Wessel D. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 62: 1759-1764, 1996.
3. Atz AM and Wessel DL. Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 21: 441-455, 1997.
4. Black SM, Bekker J, Johengen M, Soifer SJ, Parry AJ, and Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97-106, 2000.
5. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, and Fineman JR. Inhaled nitric oxide inhibits nitric oxide synthase activity in lambs. A potential mechanism for rebound pulmonary hypertension. Am J Physiol Heart Circ Physiol 277: H1849-H1856, 1999.
6. Black SM, Johengen MJ, Ma ZD, Bristow J, and Soifer SJ. Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. J Clin Invest 100: 1448-1458, 1997.
7. Boulanger C and Luscher TF. Release of endothelin-1 from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587-590, 1990.
8. Buga GM, Griscavage JM, Rogers NE, and Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73: 808-812, 1993.
9. Canadian Inhaled Nitric Oxide Study Group and the NICHD Neonatal Research Network. The neonatal inhaled nitric oxide study in the term and near-term infant with hypoxic respiratory failure: a multicenter randomized trial. N Engl J Med 336: 597-604, 1997.
10. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, and Kourembanas S. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 130: 603-611, 1997.
11. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, and Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342: 469-474, 2000.
12. Cueto E, Lopez-Herce J, Sanchez A, and Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Pediatr 86: 1337-1339, 1997.
13. de Vroomen M, Cardozo RH, Steendijk P, Van Bel F, and Baan J. Improved contractile performance of right ventricle in response to increased RV afterload in newborn lamb. Am J Physiol Heart Circ Physiol 278: H100-H105, 2000.
14. Fineman JR, Soifer SJ, and Heymann MA. Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57: 115-134, 1995.
15. b receptors in rats. Biochem Biophys Res Commun 199: 1461-1465, 1994.
16. Giaid A and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221, 1995.
17. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, and Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739, 1993.
18. Hinson JP, Kapas S, and Cameron LA. Differential effect of endogenous and exogenous nitric oxide release of endothelin-1 from the intact perfused rat adrenal gland in situ. FEBS Lett 379: 7-10, 1996.
19. A receptor antagonism with PD-156707 on hemodynamics and renal vascular resistance in rabbits. Eur J Pharmacol 321: 295-300, 1997.
20. Iwamoto J and Morin FC. Nitric oxide inhibition varies with hemoglobin saturation. J Appl Physiol 75: 2332-2336, 1993.
21. Kourembanas S, McQuillan LP, Leung GK, and Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under normoxia and hypoxia. J Clin Invest 92: 99-104, 1993.
22. Lavoie A, Hall JB, Olson DM, and Wylam ME. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 153: 1985-1987, 1996.
23. Luscher TF, Yang Z, Tschudi M, Von Segesser L, Stulz P, Boulanger C, Siebermann R, Turnia M, and Buhler FR. Interaction between endothelin 1 and endothelium derived relaxing factor in human arteries and veins. Circ Res 66: 1088-1094, 1990.
24. Macarthur H, Warner TD, Wood EG, Corder R, and Vane JR. Endothelin-1 release from cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 200: 395-400, 1994.
25. Miller OI, Tang SF, Keech A, and Celermajer DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346: 51-52, 1995.
26. Mitsutomi N, Akashi C, Odagiri J, and Matsumura Y. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol 364: 65-73, 1999.
27. Pearl JM, Nelson DP, Manning PB, Raake JL, Schwartz SM, Shanley TP, and Wong HR. Inhaled nitric oxide is associated with increased endothelin-1 levels: a potential cause of rebound pulmonary hypertension (Abstract). Circulation 100: I-169, 1999.
28. Petrossian E, Parry AJ, Reddy VM, Akkersdijk GP, McMullan DM, Thompson L, Hendricks-Munoz KD, Hallak H, Hanley FL, and Fineman JR. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. J Thorac Cardiovasc Surg 117: 314-323, 1999.
29. Redmond EM, Cahill PA, Hodges R, Zhang S, and Sitzman JV. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J Cell Physiol 166: 469-479, 1996.
30. Reynolds EE, Keiser JA, Haleen SJ, Walker DM, Olszewski B, Schroeder RL, Taylor DG, Hwang O, Welch KM, and Flynn MA. Pharmacological characterization of PD-156707, an orally active ETA receptor antagonist. J Pharmacol Exp Ther 273: 1410-1417, 1995.
31. Roberts JD Jr, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, and Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336: 605-610, 1997.
32. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, and Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399-405, 1993.
33. Rossi DT, Hallak H, Bradford L. Liquid chromatographic assay for a butenolide endothelin antagonist (PD-156707) in plasma. J Chromatogr B Biomed Appl 677: 299-304, 1996.
34. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
35. Sheehy AM, Burson MA, and Black SM. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide. Am J Physiol Lung Cell Mol Physiol 274: L833-L841, 1998.
36. Shetty SS, Toshikazu O, Webb RL, DelGrande D, and Lapp RW. Functionally distinct endothelin b receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 191: 459-464, 1993.
37. Shimada K, Takahashi M, Ikeda M, and Tanzawa K. Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371: 140-144, 1995.
38. Turner AJ and Murphy LJ. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51: 91-102, 1996.
39. Vemulapalli S, Chiu PJS, Griscti K, Brown A, Kurowski S, and Sybertz EJ. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol 257: 95-102, 1994.
40. Xuan YT, Whorton AR, Shearer-Poor E, Boyd J, and Watkins WD. Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun 164: 326-332, 1989.
41. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.